Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Rating) dropped 3% during trading on Thursday . The stock traded as low as $12.16 and last traded at $12.16. Approximately 2,665 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 278,621 shares. The stock had previously closed at $12.53. […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Rating) shares traded down 3% on Thursday . The stock traded as low as $12.16 and last traded at $12.16. 2,665 shares were traded during mid-day trading, a decline of 99% from the average session volume of 278,621 shares. The stock had previously closed at $12.53. Analyst Upgrades and […]
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Rating) has earned an average rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month target […]
Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Rating) gapped down prior to trading on Tuesday . The stock had previously closed at $12.09, but opened at $11.74. Stoke Therapeutics shares last traded at $12.31, with a volume of 18,538 shares traded. Analyst Ratings Changes A number of brokerages have recently weighed in on STOK. […]